Table 7.
KEGG enrichment pathways for DEPs.
| Pathway | Pathway definition | Number of proteins | Proteins |
|---|---|---|---|
| ko00190 | Oxidative phosphorylation | 1 | Q5ZLR5 (connectin/fragment) |
| ko01100 | Metabolic pathways | 1 | |
| ko04260 | Cardiac muscle contraction | 1 | |
| ko04932 | Nonalcoholic fatty liver disease (NAFLD) | 1 | |
| ko05010 | Alzheimer's disease | 1 | |
| ko05012 | Parkinson's disease | 1 | |
| ko05016 | Huntington's disease | 1 | |
| ko00480 | Glutathione metabolism | 1 | A0A0A0MQ61 (uncharacterized protein) |
| ko05204 | Chemical carcinogenesis | 1 | |
| ko00980 | Metabolism of xenobiotics by cytochrome P450 | 1 | |
| ko00982 | Drug metabolism-cytochrome P450 | 1 | |
| ko00970 | Aminoacyl-tRNA biosynthesis | 1 | F1P372 (uncharacterized protein) |
Note: differentially expressed proteins (DEPs). Q5ZLR5 (cytochrome b-c1 complex subunit Rieske, mitochondrial), A0A0A0MQ61 (uncharacterized protein), F1P372 (uncharacterized protein).